Immunotechnology

The TH1/TH2 paradigm in allergy
pp. 233-244(12)
Author: Maggi E.

Determination of T-lymphocyte adhesion to endothelial cells using a novel luminescence marker
pp. 245-252(8)
Authors: Termeer C.C.; Weiss J.M.; Dittmar H.; Vanscheidt W.; Schopf E.; Simon J.C.

Three-dimensional structure of a human Fab with high affinity for tetanus toxoid
pp. 253-270(18)
Authors: Faber C.; Shan L.; Fan Z.-c.; Guddat L.W.; Furebring C.; Ohlin M.; Borrebaeck C.A.K.; Edmundson A.B.

A definitive set of oligonucleotide primers for amplifying human V regions
pp. 271-278(8)
Authors: Sblattero D.; Bradbury A.

Guided selection of antibody fragments specific for human interferon receptor 1 from a human VH- and VL-gene repertoire
pp. 279-291(13)
Authors: Watzka H.; Pfizenmaier K.; Moosmayer D.

Pathfinder selection: in situ isolation of novel antibodies
pp. 293-302(10)
Authors: Osbourn J.K.; Derbyshire E.J.; Vaughan T.J.; Field A.W.; Johnson K.S.

Therapeutic Antibody Technology 97
pp. 303-307(5)
Authors: Larrick J.W.; Gavilondo J.

Progress in programming antibody fragments to crystallize
pp. 309-317(9)
Authors: Edmundson A.B.; Borrebaeck C.A.K.